Rethinking Our COVID-19 Strategy
As of Feb 21, 2021, the COVID-19 pandemic claimed over half a million lives in the U.S., and over half of the country's population has likely had an infection. Our strategy to deal with the COVID-19 pandemic to date has been to rely very heavily on vaccination while testing and anti-viral devel...
Main Author: | Samuel Brauer |
---|---|
Format: | Article |
Language: | English |
Published: |
Andover House Inc.
2021-03-01
|
Series: | Precision Nanomedicine |
Online Access: | https://prnano.scholasticahq.com/article/21569-rethinking-our-covid-19-strategy.pdf |
Similar Items
-
Virtual Teaching in the Time of COVID-19: Rethinking Our WEIRD Pedagogical Commitments to Teacher Education
by: M'Balia Thomas
Published: (2020-12-01) -
COVID-19: rethinking risk
by: Nina Schwalbe, et al.
Published: (2020-08-01) -
Aviation world rethinking strategies after COVID-19 crises
by: Claudia DOBRE
Published: (2021-03-01) -
COVID-19: Rethinking the Lockdown Groupthink
by: Ari R. Joffe, et al.
Published: (2021-02-01) -
Rethinking Offshoring and International Marketing Strategies during the COVID-19 Pandemic
by: Luíza Fonseca, et al.
Published: (2021-02-01)